What are OSK factors?
OSK refers to three reprogramming factors often discussed in cellular rejuvenation research.
Simple answer
OSK factors are Oct4, Sox2 and Klf4, a subset of reprogramming factors used in experimental biology. Their presence in a paper does not make an intervention ready for consumers.
At a glance
What the source says
- OSK factors are used to study cellular state and reprogramming.
- Timing, delivery and expression control are core safety questions.
- Consumer claims often compress complex biology into a buzzword.
What it does not prove
- It does not prove a body-wide anti-aging therapy.
- It does not prove safety in people.
- It does not prove a commercial product uses controlled biology.
Practical takeaway
When OSK appears in a claim, ask whether the evidence is cell, animal, disease-specific trial or consumer marketing.
Ask a qualified clinician if
a claim uses reprogramming-factor language to market a product, clinic or trial.
What to watch next
- Controlled delivery systems.
- Tumor-risk and cell-identity data.
- Disease-focused human studies.
FAQs
Are OSK factors natural?
They are transcription factors involved in cell identity, but therapeutic use would be a major biomedical intervention.
Does OSK mean Yamanaka factors?
OSK is a three-factor subset related to the broader reprogramming-factor family often discussed in this area.
Source links
- Approved cellular and gene therapy products - FDA
Current FDA product list should be checked before publication.
- ClinicalTrials.gov - NIH / NLM
Registry for trial status, endpoints and sponsors.
- PubMed - NIH / NLM
Primary literature search starting point.
Get the weekly longevity evidence briefing.
One plain-English email on the claims, studies and regulatory updates worth knowing - without protocols, hype or miracle claims.
No protocols. No miracle claims. No spam.
Related reading
Guide
What is partial epigenetic reprogramming?
Partial reprogramming tries to reset aspects of cell state without erasing identity, but it remains frontier biology.
Guide
Approved gene therapy vs anti-aging gene therapy.
Approved gene therapies are specific products for specific diseases; anti-aging gene therapy claims need separate evidence and regulatory scrutiny.